Ítem
Acceso Abierto

PAPP-A y β-hCG libre en el primer trimestre y el riesgo de aborto o mortinato: revisión sistemática

dc.contributor.advisorHerrera Méndez, Emiliano Mauricio
dc.contributor.advisorIbáñez Pinilla, Milcíades
dc.creatorBotero Builes, Diana Shirley
dc.creator.degreeEspecialista en Medicina Materno-Fetal
dc.creator.degreeLevelEspecialización
dc.date.accessioned2025-03-26T21:07:19Z
dc.date.available2025-03-26T21:07:19Z
dc.date.created2025-03-26
dc.descriptionLos biomarcadores (PPAP-A y β-hCG libre) reflejan la función fetoplacentaria endocrina y endotelial. Niveles bajos de PAPP-A (<0,4 MoM) o β-hCG libre (<0,5 MoM) se han asociado con un incremento en la frecuencia de desenlaces obstétricos adversos. Objetivo: Evaluar la capacidad predictiva de PAPP-A y la fracción libre de β-hCG como marcadores séricos del primer trimestre para evaluar el riesgo de aborto o mortinato. Se realizó una búsqueda sistemática en las bases electrónicas (01/01/2014-30/04/2024), para estudios que incluían gestantes con valores séricos conocidos de PAPP-A y/o β-hCG libre, que reportaron como desenlaces obstétricos adversos aborto o mortinato. Los artículos se analizaron utilizando herramientas que permitieron establecer la calidad de estos de acuerdo con el diseño de los estudios (PROBAST). Se identificaron 450 reportes en bases de datos y se seleccionaron 9 estudios que evaluaron los niveles bajos de PAPP-A y β-hCG en los desenlaces aborto y mortinato. Los estudios sugieren que niveles bajos de estos marcadores se asocian con aborto y mortinato, sin embargo, el rendimiento y la capacidad predictiva no fueron estadísticamente significativos en todos los estudios. Los niveles bajos de PAPP-A y β-hCG libre han sido utilizadas para el pronóstico de aneuploidías y trastornos de placentación, sin embargo, no parecen ser útiles para predecir el riesgo de aborto o mortinato.
dc.description.abstractBiomarkers (PPAP-A and free β-hCG) reflect endothelial and fetoplacental function. Low levels of PAPP-A (<0.4 MoM) or free β-hCG (<0.5 MoM) have been associated with an increased frequency of adverse obstetric outcomes. Objective: To evaluate the predictive capacity of PAPP-A and free β-hCG as first trimester serum markers to assess the risk of miscarriage or stillbirth. A systematic search was performed in electronic databases (2014 to April 2024) for studies that included pregnant women with known serum values of PAPP-A and/or free β-hCG, who reported miscarriage or stillbirth as adverse obstetric outcomes. Articles were analyzed using tools that allowed the quality of these to be established according to the design of the studies (PROBAST). 450 Reports were identified in databases and 9 studies were selected that evaluated low levels of PAPP-A and β-hCG in abortion and stillbirth outcomes. Studies suggest that low levels of these markers are associated with abortion and stillbirth, however, performance and predictive ability were not statistically significant in all studies. Low levels of PAPP-A and free β-hCG have been used for the prognosis of aneuploidies and placentation disorders, however, they do not seem to be useful for predicting the risk of abortion or stillbirth.
dc.format.extent55 pp
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_45161
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/45161
dc.language.isospa
dc.publisherUniversidad del Rosario
dc.publisher.departmentEscuela de Medicina y Ciencias de la Salud
dc.publisher.programEspecialización en Medicina Materno-Fetal
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.source.bibliographicCitation Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: executive summary. Disponible en: https://iris.who.int/handle/10665/327596.
dc.source.bibliographicCitation The Fetal Medicine Foundation. Disponible en: https://fetalmedicine.org/research/assess/trisomies.
dc.source.bibliographicCitation Mortalidad materna. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/maternal-mortality.
dc.source.bibliographicCitation Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. Disponible en: https://www.who.int/publications/i/item/9789240068759.
dc.source.bibliographicCitationAllen, Rebecca; Aquilina, Joseph (2018) Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes. En: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. Vol. 31; No. 21; pp. 2789 - 2806; J Matern Fetal Neonatal Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/28714317/. Disponible en: 10.1080/14767058.2017.1355903.
dc.source.bibliographicCitationBaer, Rebecca J.; Lyell, Deirdre J.; Norton, Mary E.; Currier, Robert J.; Jelliffe-Pawlowski, Laura L. (2016) First trimester pregnancy-associated plasma protein-A and birth weight. En: European journal of obstetrics, gynecology, and reproductive biology. Vol. 198; pp. 1 - 6; Eur J Obstet Gynecol Reprod Biol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/26773241/. Disponible en: 10.1016/J.EJOGRB.2015.12.019.
dc.source.bibliographicCitationBarrett, Peter M. (2021) Editorial: Adverse Pregnancy Outcomes—A Missed Opportunity to Prevent Chronic Disease?. En: International Journal of Public Health. Vol. 66; pp. 582810 - 582810; Frontiers Media S.A.; Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8336677/. Disponible en: 10.3389/IJPH.2021.582810.
dc.source.bibliographicCitationBlitz, Matthew J.; Rochelson, Burton; Vohra, Nidhi (2016) Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction. En: Clinics in Laboratory Medicine. Vol. 36; No. 2; pp. 353 - 367; Elsevier; Disponible en: 10.1016/J.CLL.2016.01.006.
dc.source.bibliographicCitationBorna, Sedigheh; Ashrafzadeh, Masoumeh; Ghaemi, Marjan; Eshraghi, Nasim; Hivechi, Nafiseh; Hantoushzadeh, Sedigheh (2023) Correlation between PAPP-A serum levels in the first trimester of pregnancy with the occurrence of gestational diabetes, a multicenter cohort study. En: BMC pregnancy and childbirth. Vol. 23; No. 1; BMC Pregnancy Childbirth; Disponible en: https://pubmed.ncbi.nlm.nih.gov/38082246/. Disponible en: 10.1186/S12884-023-06155-7.
dc.source.bibliographicCitationCuffe, James S.M.; Holland, Olivia; Salomon, Carlos; Rice, Gregory E.; Perkins, Anthony V. (2017) Review: Placental derived biomarkers of pregnancy disorders. En: Placenta. Vol. 54; pp. 104 - 110; Placenta; Disponible en: https://pubmed.ncbi.nlm.nih.gov/28117143/. Disponible en: 10.1016/J.PLACENTA.2017.01.119.
dc.source.bibliographicCitationD'Antonio, Francesco; Rijo, Claudia; Thilaganathan, Basky; Akolekar, Ranjit; Khalil, Asma; Papageourgiou, Aris; Bhide, Amar (2013) Association between first-trimester maternal serum pregnancy-associated plasma protein-a and obstetric complications. En: Prenatal Diagnosis. Vol. 33; No. 9; pp. 839 - 847; Disponible en: 10.1002/pd.4141.
dc.source.bibliographicCitationDane, Banu; Dane, Cem; Batmaz, Gonca; Ates, Seda; Dansuk, Ramazan (2013) First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. En: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. Vol. 29; No. 6; pp. 592 - 595; Gynecol Endocrinol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/23656388/. Disponible en: 10.3109/09513590.2013.788626.
dc.source.bibliographicCitationDugoff, Lorraine; Hobbins, John C.; Malone, Fergal D.; Porter, T. Flint; Luthy, David; Comstock, Christine H.; Hankins, Gary; Berkowitz, Richard L.; Merkatz, Irwin; Craigo, Sabrina D.; Timor-Tritsch, Ilan E.; Carr, Steven R.; Wolfe, Honor M.; Vidaver, John; D'Alton, Mary E. (2004) First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). En: American Journal of Obstetrics and Gynecology. Vol. 191; No. 4; pp. 1446 - 1451; Am J Obstet Gynecol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/15507981/. Disponible en: 10.1016/j.ajog.2004.06.052.
dc.source.bibliographicCitationDuley, Lelia (2009) The Global Impact of Pre-eclampsia and Eclampsia. En: Seminars in Perinatology. Vol. 33; No. 3; pp. 130 - 137; W.B. Saunders; Disponible en: 10.1053/J.SEMPERI.2009.02.010.
dc.source.bibliographicCitationFigueras, Francesc; Gratacós, Eduard (2014) Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. En: Fetal diagnosis and therapy. Vol. 36; No. 2; pp. 86 - 98; Fetal Diagn Ther; Disponible en: https://pubmed.ncbi.nlm.nih.gov/24457811/. Disponible en: 10.1159/000357592.
dc.source.bibliographicCitationFine, Michael (2024) Maternal Morbidity and Mortality, Clinicians, and Public Health: An AJPH Supplement. En: American journal of public health. Vol. 114; No. S4; pp. S299 - S301; Am J Public Health; Disponible en: https://pubmed.ncbi.nlm.nih.gov/38748962/. Disponible en: 10.2105/AJPH.2024.307693.
dc.source.bibliographicCitationGenc, Simten; Ozer, Hale; Emeklioglu, Cagdas Nurettin; Cingillioglu, Basak; Sahin, Orhan; Akturk, Erhan; Sirinoglu, Hicran Acar; Basaran, Nilgun; Mihmanli, Veli (2022) Relationship between extreme values of first trimester maternal pregnancy associated plasma Protein-A, free-β-human chorionic gonadotropin, nuchal translucency and adverse pregnancy outcomes. En: Taiwanese journal of obstetrics & gynecology. Vol. 61; No. 3; pp. 433 - 440; Taiwan J Obstet Gynecol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/35595434/. Disponible en: 10.1016/J.TJOG.2022.02.043.
dc.source.bibliographicCitationGraham, Wendy; Woodd, Susannah; Byass, Peter; Filippi, Veronique; Gon, Giorgia; Virgo, Sandra; Chou, Doris; Hounton, Sennen; Lozano, Rafael; Pattinson, Robert; Singh, Susheela (2016) Diversity and divergence: the dynamic burden of poor maternal health. En: The Lancet. Vol. 388; No. 10056; pp. 2164 - 2175; Lancet Publishing Group; Disponible en: https://www.thelancet.com/action/showFullText?pii=S0140673616315331; https://www.thelancet.com/action/showAbstract?pii=S0140673616315331; https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31533-1/abstract. Disponible en: 10.1016/S0140-6736(16)31533-1/ATTACHMENT/7E738181-75D6-462D-A8C5-5A9D3FE8DB64/MMC1.PDF.
dc.source.bibliographicCitationGupta, Sangeeta; Goyal, Manisha; Verma, Deepti; Sharma, Anjana; Bharadwaj, Namita; Kabra, Madhulika; Kapoor, Seema (2015) Adverse pregnancy outcome in patients with low pregnancy-associated plasma protein-A: The Indian Experience. En: The journal of obstetrics and gynaecology research. Vol. 41; No. 7; pp. 1003 - 1008; J Obstet Gynaecol Res; Disponible en: https://pubmed.ncbi.nlm.nih.gov/25773764/. Disponible en: 10.1111/JOG.12662.
dc.source.bibliographicCitationINS Colombia; Boletin epidemiológico semana 52-2024.
dc.source.bibliographicCitationJauniaux, Eric; Grønbeck, Lene; Bunce, Catey; Langhoff-Roos, Jens; Collins, Sally L. (2019) Epidemiology of placenta previa accreta: a systematic review and meta-analysis. En: BMJ Open. Vol. 9; No. 11; pp. e031193 - e031193; BMJ Publishing Group; Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6858111/. Disponible en: 10.1136/BMJOPEN-2019-031193.
dc.source.bibliographicCitationKaijomaa, Marja; Rahkonen, Leena; Ulander, Veli Matti; Hämäläinen, Esa; Alfthan, Henrik; Markkanen, Helene; Heinonen, Seppo; Stefanovic, Vedran (2017) Low maternal pregnancy-associated plasma protein A during the first trimester of pregnancy and pregnancy outcomes. En: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. Vol. 136; No. 1; pp. 76 - 82; Int J Gynaecol Obstet; Disponible en: https://pubmed.ncbi.nlm.nih.gov/28099695/. Disponible en: 10.1002/IJGO.12002.
dc.source.bibliographicCitationKanmaz, Ahkam Göksel; İnan, Abdurrahman Hamdi; Beyan, Emrah; Karataşlı, Volkan; Çakır, İlker; Budak, Adnan; Emirdar, Volkan (2019) Effects of fetal gender and low first trimester aneuploidy screening markers on preterm birth. En: Journal of gynecology obstetrics and human reproduction. Vol. 48; No. 8; pp. 649 - 652; J Gynecol Obstet Hum Reprod; Disponible en: https://pubmed.ncbi.nlm.nih.gov/30685427/. Disponible en: 10.1016/J.JOGOH.2019.01.011.
dc.source.bibliographicCitationKantomaa, Tiina; Vääräsmäki, Marja; Gissler, Mika; Sairanen, Mikko; Nevalainen, Jaana (2022) First trimester low maternal serum pregnancy associated plasma protein-A (PAPP-A) as a screening method for adverse pregnancy outcomes. En: Journal of perinatal medicine. Vol. 51; No. 4; pp. 500 - 509; J Perinat Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/36131518/. Disponible en: 10.1515/JPM-2022-0241.
dc.source.bibliographicCitationKrawczyk, Jozef; Ratajczak, Piotr; Sajdak, Stefan (2023) Increased risk of low infant birth weight in pregnant women with low PAPP-A values measured in the first trimester. En: Ginekologia polska. Vol. 94; No. 9; pp. 714 - 720; Ginekol Pol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/39545306/. Disponible en: 10.5603/GP.A2022.0118.
dc.source.bibliographicCitationLawrence, Emma R.; Klein, Thomas J.; Beyuo, Titus K. (2022) Maternal Mortality in Low and Middle-Income Countries. En: Obstetrics and Gynecology Clinics of North America. Vol. 49; No. 4; pp. 713 - 733; W.B. Saunders; Disponible en: 10.1016/j.ogc.2022.07.001.
dc.source.bibliographicCitationMartell Claros, N. (2017) La hipertensión arterial en la embarazada. En: Hipertens. riesgo vasc. Vol. 34; pp. 22 - 25; Ediciones Doyma, S.L.; Disponible en: 10.1016/S1889-1837(18)30071-0.
dc.source.bibliographicCitationMasihi, Sara; Amirgholami, Bahar; Nourian, Bahare; Zamani Behbahani, Shabnam; Khezri, Mahda; Javid, Fatemeh (2025) Association of First-Trimester Low PAPP-A Levels (&lt;0.2 MoM) with Maternal and Fetal Outcomes. En: European Journal of Medical and Health Sciences. Vol. 7; No. 1; pp. 10 - 14; Disponible en: https://www.ejmed.org/index.php/ejmed/article/view/2233. Disponible en: 10.24018/EJMED.2025.7.1.2233.
dc.source.bibliographicCitationMohamad Jafari, Razyeh; Masihi, Sara; Barati, Mojgan; Maraghi, Elham; Sheibani, Somayeh; Sheikhvatan, Mehrdad; Jafari, Mohamad R; Masihi, Sara S; Author, Corresponding (2019) Value of Pregnancy-Associated Plasma Protein-A for Predicting Adverse Pregnancy Outcome. En: Arch Iran Med. Vol. 22; No. 10; pp. 584 - 587; Disponible en: www.aimjournal.ir.
dc.source.bibliographicCitationMohammed, Khitam; Shaban, Insaf; Al-Akour, Nemeh; Kassab, Manal; Creedy, Debra (2020) Low birth weight in Jordan: a hospital-based study. En: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. Vol. 33; No. 18; pp. 3050 - 3055; J Matern Fetal Neonatal Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/30621482/. Disponible en: 10.1080/14767058.2019.1567707.
dc.source.bibliographicCitationNicolaides, Kypros H. (2005) First-trimester screening for chromosomal abnormalities. En: Seminars in perinatology. Vol. 29; No. 4; pp. 190 - 194; Semin Perinatol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/16104667/. Disponible en: 10.1053/J.SEMPERI.2005.06.001.
dc.source.bibliographicCitationNicolaides, Kypros H; Falcón, Orlando (2004) La ecografía de las 11-13 +6 semanas.
dc.source.bibliographicCitationOdibo, A. O.; Patel, K. R.; Spitalnik, A.; Odibo, L.; Huettner, P. (2014) Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. En: Journal of Perinatology 2014 34:3. Vol. 34; No. 3; pp. 186 - 191; Nature Publishing Group; Disponible en: https://www.nature.com/articles/jp2013176. Disponible en: 10.1038/jp.2013.176.
dc.source.bibliographicCitationOyelese, Yinka; Ananth, Cande V. (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. En: Clinical obstetrics and gynecology. Vol. 53; No. 1; pp. 147 - 156; Clin Obstet Gynecol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/20142652/. Disponible en: 10.1097/GRF.0B013E3181CC406D.
dc.source.bibliographicCitationOzdemir, Savas; Sahin, Orhan; Acar, Zuat; Demir, Gozde Zeynep; Ermin, Ece; Aydin, Alev (2022) Prediction of Pregnancy Complications With Maternal Biochemical Markers Used in Down Syndrome Screening. En: Cureus. Vol. 14; No. 3; Cureus; Disponible en: https://pubmed.ncbi.nlm.nih.gov/35425672/. Disponible en: 10.7759/CUREUS.23115.
dc.source.bibliographicCitationPapamichail, Maria; Fasoulakis, Zacharias; Daskalakis, George; Theodora, Marianna; Rodolakis, Alexandros; Antsaklis, Panagiotis (2022) Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women. En: Cureus. Vol. 14; No. 11; Cureus; Disponible en: https://pubmed.ncbi.nlm.nih.gov/36505175/. Disponible en: 10.7759/CUREUS.31256.
dc.source.bibliographicCitationPoon, Liona C.; Shennan, Andrew; Hyett, Jonathan A.; Kapur, Anil; Hadar, Eran; Divakar, Hema; McAuliffe, Fionnuala; da Silva Costa, Fabricio; von Dadelszen, Peter; McIntyre, Harold David; Kihara, Anne B.; Di Renzo, Gian Carlo; Romero, Roberto; D'Alton, Mary; Berghella, Vincenzo; Nicolaides, Kypros H.; Hod, Moshe (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. En: International Journal of Gynecology & Obstetrics. Vol. 145; No. S1; pp. 1 - 33; John Wiley & Sons, Ltd; Disponible en: https://onlinelibrary-wiley-com.ez.urosario.edu.co/doi/full/10.1002/ijgo.12802; https://onlinelibrary-wiley-com.ez.urosario.edu.co/doi/abs/10.1002/ijgo.12802; https://obgyn-onlinelibrary-wiley-com.ez.urosario.edu.co/doi/10.1002/ijgo.12802. Disponible en: 10.1002/IJGO.12802.
dc.source.bibliographicCitationPornwattanakrilert, Weerawich; Sekararithi, Ratanaporn; Wanapirak, Chanane; Sirichotiyakul, Supatra; Tongprasert, Fuanglada; Srisupundit, Kasemsri; Luewan, Suchaya; Tongsong, Theera (2020) First-trimester serum biomarker screening for fetal Down syndrome as a predictor of preterm delivery: a population-based study. En: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. Vol. 33; No. 10; pp. 1717 - 1724; J Matern Fetal Neonatal Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/30371129/. Disponible en: 10.1080/14767058.2018.1529162.
dc.source.bibliographicCitationQuattrocchi, Tommasa; Baviera, Giovanni; Pochiero, Teresa; Basile, Francesca; Rizzo, Laura; Santamaria, Angelo; Corrado, Francesco; D'Anna, Rosario (2015) Maternal serum PAPP-A as an early marker of obstetric complications?. En: Fetal diagnosis and therapy. Vol. 37; No. 1; pp. 33 - 36; Fetal Diagn Ther; Disponible en: https://pubmed.ncbi.nlm.nih.gov/25139218/. Disponible en: 10.1159/000365147.
dc.source.bibliographicCitationQuenby, Siobhan; Gallos, Ioannis D.; Dhillon-Smith, Rima K.; Podesek, Marcelina; Stephenson, Mary D.; Fisher, Joanne; Brosens, Jan J.; Brewin, Jane; Ramhorst, Rosanna; Lucas, Emma S.; McCoy, Rajiv C.; Anderson, Robert; Daher, Shahd; Regan, Lesley; Al-Memar, Maya; Bourne, Tom; MacIntyre, David A.; Rai, Raj; Christiansen, Ole B.; Sugiura-Ogasawara, Mayumi; Odendaal, Joshua; Devall, Adam J.; Bennett, Phillip R.; Petrou, Stavros; Coomarasamy, Arri (2021) Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. En: Lancet (London, England). Vol. 397; No. 10285; pp. 1658 - 1667; Lancet; Disponible en: https://pubmed.ncbi.nlm.nih.gov/33915094/. Disponible en: 10.1016/S0140-6736(21)00682-6.
dc.source.bibliographicCitationRolnik, Daniel L.; Nicolaides, Kypros H.; Poon, Liona C. (2022) Prevention of preeclampsia with aspirin. En: American Journal of Obstetrics and Gynecology. Vol. 226; No. 2; pp. S1108 - S1119; Mosby; Disponible en: 10.1016/J.AJOG.2020.08.045.
dc.source.bibliographicCitationSmith, Gordon C.S.; Shah, Imran; Crossley, Jennifer A.; Aitken, David A.; Pell, Jill P.; Nelson, Scott M.; Cameron, Alan D.; Connor, Michael J.; Dobbie, Richard (2006) Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. En: Obstetrics and gynecology. Vol. 107; No. 1; pp. 161 - 166; Obstet Gynecol; Disponible en: https://pubmed.ncbi.nlm.nih.gov/16394054/. Disponible en: 10.1097/01.AOG.0000191302.79560.D8.
dc.source.bibliographicCitationSovio, Ulla; Gaccioli, Francesca; Cook, Emma; Charnock-Jones, D. Stephen; Smith, Gordon C.S. (2024) Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study. En: BJOG : an international journal of obstetrics and gynaecology. Vol. 131; No. 6; pp. 823 - 831; BJOG; Disponible en: https://pubmed.ncbi.nlm.nih.gov/37822261/. Disponible en: 10.1111/1471-0528.17691.
dc.source.bibliographicCitationTikkanen, Minna (2011) Placental abruption: epidemiology, risk factors and consequences. En: Acta obstetricia et gynecologica Scandinavica. Vol. 90; No. 2; pp. 140 - 149; Acta Obstet Gynecol Scand; Disponible en: https://pubmed.ncbi.nlm.nih.gov/21241259/. Disponible en: 10.1111/J.1600-0412.2010.01030.X.
dc.source.bibliographicCitationTsibizova, Valentina; Al-Sannan, Baydaa; Fedorova, Anna; Govorov, Igor; Meyyazhagan, Arun; Di Renzo, Gian Carlo (2024) Can we improve the outcome of pregnancies with low serum PAPP-A in the first trimester?. En: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. Vol. 37; No. 1; J Matern Fetal Neonatal Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/38503546/. Disponible en: 10.1080/14767058.2024.2326303.
dc.source.bibliographicCitationTurner, Jessica M.; Kumar, Sailesh (2020) Low First Trimester Pregnancy-Associated Plasma Protein-A Levels Are Not Associated with an Increased Risk of Intrapartum Fetal Compromise or Adverse Neonatal Outcomes: A Retrospective Cohort Study. En: Journal of clinical medicine. Vol. 9; No. 4; J Clin Med; Disponible en: https://pubmed.ncbi.nlm.nih.gov/32294920/. Disponible en: 10.3390/JCM9041108.
dc.source.bibliographicCitationValbuena, Henar; Ramis, Jordi; Sagalá, Juan; Sánchez, M. Ángeles; Aulesa, Carlos (2015) First-trimester screening biochemical markers (free beta-subunit human chorionic gonadotropin, pregnancy-associated plasma protein-A) and risk of early fetal loss. En: The journal of obstetrics and gynaecology research. Vol. 41; No. 1; pp. 69 - 76; J Obstet Gynaecol Res; Disponible en: https://pubmed.ncbi.nlm.nih.gov/25159705/. Disponible en: 10.1111/JOG.12490.
dc.source.bibliographicCitationWalani, Salimah R. (2020) Global burden of preterm birth. En: International Journal of Gynecology & Obstetrics. Vol. 150; No. 1; pp. 31 - 33; John Wiley & Sons, Ltd; Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/ijgo.13195; https://onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.13195; https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.13195. Disponible en: 10.1002/IJGO.13195.
dc.source.bibliographicCitationZhong, Yan; Zhu, Fufan; Ding, Yiling (2015) Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: Systematic review and meta-analysis. En: BMC Pregnancy and Childbirth. Vol. 15; No. 1; pp. 1 - 10; BioMed Central Ltd.; Disponible en: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-015-0608-y. Disponible en: 10.1186/S12884-015-0608-Y/FIGURES/10.
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subjectResultados adversos del embarazo
dc.subjectPrimer trimestre
dc.subjectFracción libre β-Gonadotropina coriónica humana
dc.subjectProteína plasmática A asociada al embarazo
dc.subjectAborto
dc.subjectÓbito
dc.subject.keywordAdverse pregnancy outcomes
dc.subject.keywordFirst trimester
dc.subject.keywordFree fraction β-Human chorionic gonadotropin
dc.subject.keywordPregnancy-associated plasma protein a
dc.subject.keywordAbortion
dc.subject.keywordStillbirth
dc.titlePAPP-A y β-hCG libre en el primer trimestre y el riesgo de aborto o mortinato: revisión sistemática
dc.title.TranslatedTitleFirst-trimester papp-a and free b-hcg and the risk of miscarriage or stillbirth: a systematic review
dc.typemasterThesis
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de grado
local.department.reportEscuela de Medicina y Ciencias de la Salud
local.regionesBogotá
Archivos
Bloque original
Mostrando1 - 2 de 2
Cargando...
Miniatura
Nombre:
Pappa_y_bhcg_libre_en_el_primer_trimestre.pdf
Tamaño:
816.42 KB
Formato:
Adobe Portable Document Format
Descripción:
Cargando...
Miniatura
Nombre:
Pappa_y_bhcg_libre_en_el_primer_trimestre.ris
Tamaño:
105.88 KB
Formato:
Descripción: